ask="6.15"
ask_size="2200"
average_daily_volume="313905"
bid="6.05"
bid_size="100"
book_value="3.69"
change="-0.25"
change_from_200_day_moving_average="-4.27"
change_from_50_day_moving_average="-4.75"
change_from_52_week_high="-8.30"
change_From_52_week_low="2.42"
change_in_percent="-3.82%"
close="6.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.08"
ex_dividend_date="N/A"
float_shares="16060000"
high="6.65"
high_52_weeks="14.60"
last_trade_date="2/6/2017"
last_trade_price="6.30"
last_trade_size="13557"
last_trade_time="4:00pm"
low="6.10"
low_52_weeks="3.88"
market_capitalization="112.43M"
moving_average_200_day="10.57"
moving_average_50_day="11.05"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="27.50"
open="6.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-40.40%"
percent_change_from_50_day_moving_average="-43.00%"
percent_change_from_52_week_high="-56.85%"
percent_change_from_52_week_low="+62.37%"
previous_close="6.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.78"
price_per_sales="123.35"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.27"
stock_exchange="NCM"
symbol="STML"
volume="546071"
weeks_range_52="3.88 - 14.60"
